Start free

PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
BCBS TexasAll Plans · Billing Codes · Reimbursement · TX · Ophthalmology, EndocrinologyHigh impact

New Claims Editing Rules To Be Implemented in December 2026

Act
by Nov 15, 2026
Effective date
Dec 1, 2026
Identified
Aug 22, 2026

Summary

Blue Cross Blue Shield of Texas is implementing new claims editing rules effective December 1, 2026, that will enforce specific unit limits on five specialty injectable drugs (Denosumab, Aflibercept, Ranibizumab, Pasireotide, and Ranibizumab-eqrn) and require proper application of drug wastage modifiers on single-use vial claims. Claims that fail these edits will receive ineligible reason codes beginning with 'G.' Billing teams must update systems and provider education to comply with these new frequency and unit limitations.

Get alerts when payers change rules like this one

We check BCBS Texas and other payers every day and email you when a change matches your specialty and state.

Get BCBS Texas alertsPolicy Monitoring is free. No card required.

What to do

by Nov 15, 2026 · 6 steps
01Billing team must update Lyric software and claims editing system to enforce the following unit limits: J0897 (Denosumab) maximum 60 units every 6 months for osteoporosis diagnosis; J0178 (Aflibercept) maximum 4 units every 4 weeks; J2778 (Ranibizumab) maximum 5 units every 4 weeks; J2502 (Pasireotide) maximum 60 units every 4 weeks for acromegaly diagnosis; Q5128 (Ranibizumab-eqrn) maximum 10 units every 4 weeks for wet AMD, RVO, or myopic CNV diagnoses.
02Additionally, configure system to flag single-use vial/package drug codes missing JW or JZ drug wastage modifiers.
03Notify all providers and clinical staff of these new limits via training session or written communication.
04Update billing templates and charge capture forms to include these code-specific limits.
05Configure system to generate 'G' prefixed denial codes for failed edits.
06Establish audit process to review denied claims post-implementation.
If missed: Failure to comply will result in claim denials and revenue loss for affected specialty drug administrations.

Codes mentioned

J0897J0178J2778J2502Q5128

Original notice

New Claims Editing Rules To Be Implemented in December 2026
bcbstx.com · Always check the source before changing claims.
View original ↗

Related policy hubs

BCBS Texas policiesTX policy changesOphthalmologyEndocrinologyCode J0897Code J0178Code J2778Code J2502Code Q5128

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Policy MonitoringPayer policy, prior auth and coding changes, filtered to your saved searchesOIG ScreeningStaff and vendors screened every month against OIG LEIE, SAM.gov and state Medicaid listsPrior Auth LookupKnow if a service needs prior authorization before you schedule itCredentialing TrackerLicenses, CAQH, Medicare revalidation and payer enrollments, with reminders before anything lapsesCompliance CenterKeep your HIPAA program documented and ready to show
Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account